Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCORI Board Lays CER Groundwork With Environmental Scans, “Tier 1” Grants

Executive Summary

The Patient-Centered Outcomes Research Institute board of governors approved two actions that are expected to form the foundation of its future work: conducting environmental scans and developing the process for awarding “tier 1” grants.

You may also be interested in...



Patient Engagement A Key Part Of PCORI’s “Tier 1” Grants

NEW YORK – Although the list of topics to be researched with “tier 1” grants from the Patient-Centered Outcomes Research Institute will not be finalized until sometime in June, one area that is sure to garner funding opportunities will be finding ways to engage patients as stakeholders.

Patient Engagement A Key Part Of PCORI’s “Tier 1” Grants

NEW YORK – Although the list of topics to be researched with “tier 1” grants from the Patient-Centered Outcomes Research Institute will not be finalized until sometime in June, one area that is sure to garner funding opportunities will be finding ways to engage patients as stakeholders.

PCORI Names Experienced Research Leader, Joe Selby, As Executive Director

Selby will be responsible for implementing research programs authorized by the board of the Patient-Centered Outcomes Research Institute.

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS053214

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel